Familial pituitary adenomas;Adénomes hypophysaires familiaux

Presse Medicale

Volumn 38, Issue 1, 2009, Pages 112-116

  Burlacu, Maria Cristina ^a   Tichomirowa, Maria ^a   Daly, Adrian ^a   Beckers, Albert ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B;

CARNEY COMPLEX; DISEASE COURSE; ENDOCRINE TUMOR; FAMILIAL PITUITARY ADENOMA; GENE MUTATION; HUMAN; HYPOPHYSIS ADENOMA; PATHOGENESIS; PHENOTYPE; SHORT SURVEY;

ADENOMA; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PHENOTYPE; PITUITARY NEOPLASMS; PROTO-ONCOGENE PROTEINS; RNA-BINDING PROTEINS;

EID: 57949116244     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.09.011     Document Type: Short Survey

References (33)

1. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 16 3 (1954) 363-371
2. Bailey P., and Cushing H. The microscopic structure of the adenomas in acromegalic dyspituitarism (fugitive acromegaly). Am J Pathol (1928) 545-563
3. Daly A.F., Rixhon M., Adam C., Dempegioti A., Tichomirowa M.A., Beckers A., et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91 (2006) 4769-4775
4. Daly A., Jaffrain-Rea M.L., Ciccarelli A., Valdes-Socin H., Rohmer V., Tamburrano G., et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91 (2006) 3316-3323
5. Beckers A., and Daly A. The clinical, pathological and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 157 (2007) 1-13
6. Poncin J., Stevenaert A., and Beckers A. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. Eur J Endocrinol 140 (1999) 573-576
7. Barlier A., Vanbellinghen J.F., Daly A.F., Silvy M., Jaffrain-Rea M.L., Trouillas J., et al. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab 92 (2007) 1952-1955
8. Lemos M.C., and Thakker R.V. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29 (2008) 22-32
9. Burgess J.R., Nord B., David R., Greenaway T.M., Parameswaran V., Larsson C., et al. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1). Clin Endocrinol (Oxf) 53 (2000) 205-211
10. Georgitsi M., Raitila A., Karhu A., Tuppurainen K., Mäkinen M.J., Vierimaa O., et al. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc Natl Acad Sci U S A 104 (2007) 4101-4105
11. Igreja S, Chahal HS, Akker SA, Gueorguiev M, Popovic V, Damjanovic S et al. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and AIP (aryl hydrocarbon receptor-interacting protein) genes in MEN1 syndrome patients without any detectable MEN1 gene mutations. Clin Endocrinol (Oxf) 2008; [Epub ahead of print: Aug 15; DOI 10.1111/j.1365-2265.2008.03379.x]. 2006.
12. Skogseid B., Eriksson B., Lundqvist G., Lörelius L.E., Rastad J., Wide L., et al. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73 2 (1991) 281-287
13. Burgess J.R., Shepherd J.J., Parameswaran V., Hoffman L., and Greenaway T.M. Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred. J Clin Endocrinol Metab 81 7 (1996) 2642-2646
14. Verges B., Boureille F., Goudet P., Murat A., Beckers A., Sassolas G., et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 87 (2002) 457-465
15. Olufemi S.E., Green J.S., Manickam P., Guru S.C., Agarwal S.K., Kester M.B., et al. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Hum Mutat 11 4 (1998) 264-269
16. Hao W., Skarulis M.C., Simonds W.F., Weinstein L.S., Agarwal S.K., Mateo C., et al. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. J Clin Endocrinol Metab 89 8 (2004) 3776-3784
17. Piotrowska K., Pellegata N.S., Rosemann M., Fritz A., Graw J., and Atkinson M.J. Mapping of a novel MEN-like syndrome locus to rat chromosome 4. Mamm Genome 15 2 (2004) 135-141
18. Pellegata N.S., Quintanilla-Martinez L., Keller G., Samson E., Bink K., Höfler H., et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 103 (2006) 15558-15563
19. Georgitsi M., Raitila A., Karhu A., van der Luijt R.B., Aalfs C.M., Sane T., et al. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92 8 (2007) 3321-3325
20. Ozawa A., Agarwal S.K., Mateo C.M., Burns A.L., Rice T.S., Kennedy P.A., et al. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. J Clin Endocrinol Metab 92 (2007) 1948-1951
21. Stratakis C.A., Kirschner L.S., and Carney J.A. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86 9 (2001) 4041-4046
22. Stratakis C.A., Carney J.A., Lin J.P., Papanicolaou D.A., Karl M., Kastner D.L., et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 97 3 (1996) 699-705
23. Boikos S.A., and Stratakis C.A. Carney complex: the first 20 years. Curr Opin Oncol 19 (2007) 24-29
24. Boikos S.A., and Stratakis CA. Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Pituitary 9 (2006) 203-209
25. Verloes A., Stevenaert A., Teh B.T., Petrossians P., and Beckers A. Familial acromegaly: case report and review of the literature. Pituitary 1 (1999) 273-277
26. Luccio-Camelo D.C., Une K.N., Ferreira R.E., Khoo S.K., Nickolov R., Bronstein M.D., et al. A meiotic recombination in a new isolated familial somatotropinoma kindred. Eur J Endocrinol 150 (2004) 643-648
27. van der Lely AJ, Beckers A, Daly AF, Lamberts SWJ, Clemmons DR. Epidemiology, pathology and complications of acromegaly. In: Acromegaly. pathology, diagnosis and treatment. Taylor&Francis Group: 2005; pp 39-70.
28. Berezin M., and Karasik A. Familial prolactinoma. Clin Endocrinol (Oxf) 42 5 (1995) 483-486
29. Salti I.S., and Mufarrij I.S. Familial Cushing Disease. Am J Med Genet 8 1 (1981) 91-94
30. Yuasa H., Tokito S., Nakagaki H., and Kitamura K. Familial pituitary adenoma-report of four cases from two unrelated families. Neurol Med Chir (Tokyo) 30 13 (1990) 1016-1019
31. Vierimaa O., Georgitsi M., Lehtonen R., Vahteristo P., Kokko A., Raitila A., et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 (2006) 1228-1230
32. Daly A., Vanbellinghen J.F., Khoo S.K., Jaffrain-Rea M.L., Naves L.A., Guitelman M.A., et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92 (2007) 1891-1896
33. Toledo R.A., Lourenço Jr. D.M., Liberman B., Cunha-Neto M.B., Cavalcanti M.G., Moyses C.B., et al. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. J Clin Endocrinol Metab 92 5 (2007) 1934-1937